Dr. Priska Sarpanec
CEO
Replay available
Jenoptik AG (LSE: 0ZPV) Q1 2026 earnings conference call, held 2026-05-12. Replay captured from the company's public earnings webcast.

CEO
Analyst
Good morning, ladies and gentlemen, and welcome to the Jenoptik Conference Call regarding the results of the First Quarter of twenty twenty six. At this time, all participants have been placed on a listen only mode. The floor will be open for questions following the presentation. Let me now turn the floor over to your host, Doctor. Prisca Sarbanak. Good morning, everyone, and welcome to our Q1 twenty twenty six results call. I will lead you through our presentation. And then, as always, Andreas, our Head of Investor Relations, and I will be open for your questions. Now let me begin with an overview and some key messages on page four of our slide deck. First of all, I'm very pleased to report that order intake was very strong for our OEM businesses in the first quarter, as we already indicated on our previous call at the end of March. Ramp up in the semi industry seems to be in full swing now, hence demand for our semi equipment customers was particularly strong. But also, order intake in our biophotonics business unit was substantially up compared to last year. Revenues for the quarter were slightly down year on year, as we expected, and I had indicated on our last call. We are also pleased, I can say, with the evolution of our profitability in terms of EBITDA margin in Q1. Noting, however, as you know, that Q1 does not represent a modest comp if you look at last year. Free cash flow in Q1 was down year on year, reflecting higher working capital needs in conjunction with our accelerating order intake. Now taking a broader view at our company and at our strengths. We continue to believe that we have established very strong positions in certain end markets, combining a well developed technological base with strong long term customer relationships. And looking forward, ...